Global generic prescription drug revenues as share of prescribed revenue 2010-2024

This statistic depicts the generic prescription drug revenue worldwide from 2010 to 2024 as a percentage of total prescribed drugs revenue. In 2019, the industry is expected to generate 9.4 percent of its prescribed sales from generic prescription drug revenues worldwide.

Worldwide generic prescription drug revenue as a percent of total prescribed revenue from 2010 to 2024

Percentage of total prescription drug revenue
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

June 2019

Region

Worldwide

Survey time period

as of May 2019

Supplementary notes

Sales to 2018 based on company reported sales data. Sales forecasts to 2022 based on a consensus of leading equity analysts’ estimates for company product sales and segmental sales.
* Projected.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Generics and biosimilars"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.